Search results
Results from the WOW.Com Content Network
21 Medicine, pharmaceutical and health sciences. 22 Music. 23 Nutrition. 24 Philosophy. 25 Physics. ... Annals of Saudi Medicine; Bangladesh Journal of Pharmacology;
NNC9204-1706 or NN9423 is a GLP-1/GIP/glucagon receptor triple agonist developed by Novo Nordisk. [1] [2] It was evaluated in a clinical trial; [3] [4] adverse effects such as "dose-dependent increases in heart rate and reductions in reticulocyte count, increases in markers of inflammation and hepatic disturbances, and impaired glucose tolerance at the highest dosages" meant that the drug was ...
Journal of Pharmaceutical Research and Clinical Practice; Journal of Pharmacology and Pharmacotherapeutics; ... Saudi Journal for Health Sciences;
The Annals of Saudi Medicine is a bimonthly peer-reviewed medical journal published by the King Faisal Specialist Hospital and Research Centre (Riyadh, Saudi Arabia). It was established in 1981 as the King Faisal Specialist Hospital Medical Journal and obtained its current name in 1985. Publication frequency increased from quarterly to ...
The Journal of Clinical Pharmacology; Journal of Controlled Release; Journal of Ethnopharmacology; Journal of Generic Medicines; Journal of Microencapsulation; Journal of Oncology Pharmacy Practice; Journal of Pharmacy Practice; Journal of Pharmaceutical Sciences; Journal of Pharmacy and Bioallied Sciences; Journal of Pharmacy and ...
According to the Journal Citation Reports, the journal had a 2014 impact factor of 0.588. [1] The journal has been in the Thomson-Reuters database since 1992. [2] The journal is indexed in the following bibliographic databases: Saudi Medical Journal is a member of the Committee on Publication Ethics (COPE)
Cabergoline, sold under the brand name Dostinex among others, is a dopaminergic medication used in the treatment of high prolactin levels, prolactinomas, Parkinson's disease, and for other indications. [2]
The FDA can require a pharmaceutical company to place a boxed warning. It is the strongest warning that the FDA requires, and signifies that medical studies indicate that the drug carries a significant risk of preventable, serious or even life-threatening adverse effects .